Kioxia Holdings Corporation Wins IPO of the Year Award in the Equity Category at the DealWatch Awards 2024
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced that it had won the IPO of the Year award in the Equity category at the DealWatch Awards 2024, organized by DealWatch, the most authoritative source of real-time intelligence for deal activity within Japan's capital markets. The award was presented at a ceremony held on May 20.
The DealWatch Awards recognize outstanding issuers of bonds or equities in the Japanese capital market, as well as Japanese issuers who have conducted offerings overseas, and the securities firms that manage these transactions. The awards for 2024 comprised six categories: Overall, Bonds, Local Government Bonds, Cross-Border Bonds, Sustainable Finance, and Equity. Selection is based on criteria such as the appropriateness of pricing in the issuance market, price formation after transition to the trading market, contribution to the development of capital markets, and innovative efforts, with the awards designed to promote Japan's markets to a global audience.
DealWatch commented positively on our listing on the Tokyo Stock Exchange Prime Market on December 18, 2024, stating it was "an unprecedented large-scale IPO adopting Japan's first pre-approval notification (S-1) procedure.” They added, “Active discussions were conducted with institutional investors regarding appropriate pricing, effectively promoting the growth potential of the NAND market and the company's competitive edge, thereby stimulating demand from individual investors and institutional investors both domestically and internationally. This resulted in extremely strong after-market performance."
Moving forward, the Kioxia Group remains committed to fulfilling its corporate social responsibilities and striving for sustainable growth and enhanced corporate value to meet the expectations of its stakeholders.
About Kioxia
Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with “memory” by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, automotive systems, data centers and generative AI systems.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250523319080/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting starter samarbejde med 2i Solutions23.5.2025 12:39:00 CEST | Pressemeddelelse
Andersen Consulting udvider nu sine teknologiske og transformationsmæssige kapaciteter med en samarbejdsaftale med 2i Solutions, der er en virksomhed inden for teknologirådgivning, som bidrager med dybdegående ekspertise inden for ERP og andre specialiserede teknologier for at levere omfattende digitale transformationsløsninger til kunder. 2i Solutions blev grundlagt i 2005 og rådgiver kunder om teknologisk transformation af virksomheder med speciale i implementering, support og tilpasning af SAP. Virksomheden har et stærkt fokus på at levere intelligente forretningsløsninger og tilbyder tjenester inden for SAP S/4HANA-migrering, cloudløsninger, dataanalyse, kunstig intelligens og automatisering af forretningsprocesser. 2i Solutions samarbejder med en bred vifte af kunder inden for forsyning, forsikring, lægemiddelindustrien og fremstillingsbranchen, herunder også den offentlige sektor. Deres branchespecifikke løsninger og globale kapaciteter gør dem i stand til at hjælpe virksomheder,
Reply Announces the Jury for the First AI Music Contest: Finalists Will Perform Live on Stage at Kappa FuturFestival in Turin23.5.2025 10:05:00 CEST | Press release
The jury of the first contest connecting artificial intelligence with the world of live performance comprises the following DJs and artists: Albertino, Nicola Gotti, Jacopo Di Cera, DJ Tennis, Damir Ivic, Ali Demirel, Ale Lippi, Auronda Scalera & Alfredo Cramerotti, Annibale Siconolfi, Seth Troxler. Reply, an international group specialized in the creation of new business models enabled by Artificial Intelligence and driven by a strong culture of innovation, is expanding its creative experimentation initiatives this year with the launch of the AI Music Contest. Organised in collaboration with Kappa FuturFestival, one of Europe’s leading electronic music festivals, the competition is open to creatives and innovators who use AI technologies to explore new forms of integration between sound and visuals. It aims to enhance the expressive potential of artificial intelligence in live performances. This press release features multimedia. View the full release here: https://www.businesswire.co
Generix Named in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS) for the Seventh Consecutive Year23.5.2025 09:00:00 CEST | Press release
Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces it has been recognized by Gartner in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS). This is the seventh consecutive year that Generix has been recognized for its portfolio of WMS Solutions. Designed to scale as supply chain operations grow from simple to complex flows, Generix WMS and Solochain WMS are currently in more than 2,000 warehouses globally. “We are honored to be recognized in the Gartner® Magic Quadrant™ WMS for the seventh consecutive year. Generix continues its commitment to providing WMS for every warehousing need at a global scale. With our two recognized WMS solutions, Generix WMS and Solochain WMS, we continue to innovate to better serve customer needs with the introduction of industry game-changing AI use-cases such as resource planning and computer vision,” said Si-Mohamed Sa
NuORDER by Lightspeed and Mandatory Renew Partnership to Power Hybrid Commerce at the Third Edition of the Copenhagen Event23.5.2025 09:00:00 CEST | Press release
Third edition of the trade event will merge physical and digital experiences, supporting the vibrant and fast-growing Nordic fashion community Mandatory and NuORDER by Lightspeed, the industry’s leading B2B commerce platform, are joining forces for the third consecutive time to power the digital extension of Mandatory’s in-person trade event, taking place August 5–7 in Copenhagen. This renewed partnership reflects the continued momentum behind hybrid commerce—where physical and digital trade intersect to create smarter, more flexible buying experiences. As the Nordic fashion ecosystem expands with energy and innovation, Mandatory has become a magnet for trendsetting brands and forward-looking retailers. On NuORDER’s wholesale platform, buyer activity from Nordic-region retailers surged by 39.4% year over year in Q1 2025 (January to March). "Retailers in the Nordic region have been quick to adopt digital tools to enhance the efficiency of their buying processes. The increase in buyer ac
Curatis discloses Corticorelin as active substance of C-PTBE-0123.5.2025 07:00:00 CEST | Press release
Corticorelin Market Opportunity in Peritumoral Brain Edema (PTBE) expected to exceed USD 1 billion; Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute significantly to the quality of life of many patients, combined with the potential of maintaining the efficacy of immunotherapies for these patients, is very motivating and exciting,” said Dr. Roland Rutschmann, Curatis CEO. Key statements Corticorelin (hCRH), a 41 amino acid endogenous polypeptide, has demonstrated the ability to positively imp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom